• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子受体2的表达表征了Toll样受体9驱动的产生白细胞介素-10的B细胞的形成。

Expression of Tumor Necrosis Factor Receptor 2 Characterizes TLR9-Driven Formation of Interleukin-10-Producing B Cells.

作者信息

Ticha Olga, Moos Lukas, Wajant Harald, Bekeredjian-Ding Isabelle

机构信息

Division of Microbiology, Paul-Ehrlich-Institut, Langen, Germany.

Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany.

出版信息

Front Immunol. 2018 Jan 19;8:1951. doi: 10.3389/fimmu.2017.01951. eCollection 2017.

DOI:10.3389/fimmu.2017.01951
PMID:29403470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5780339/
Abstract

B cell-derived interleukin-10 (IL-10) production has been described as a hallmark for regulatory function in B lymphocytes. However, there is an ongoing debate on the origin of IL-10-secreting B cells and lack of specific surface markers has turned into an important obstacle for studying human B regulatory cells. In this study, we propose that tumor necrosis factor receptor 2 (TNFR2) expression can be used for enrichment of IL-10-secreting B cells. Our data confirm that IL-10 production can be induced by TLR9 stimulation with CpG ODN and that IL-10 secretion accompanies differentiation of peripheral blood B cells into plasma blasts. We further show that CpG ODN stimulation induces TNFR2 expression, which correlates with IL-10 secretion and terminal differentiation. Indeed, flow cytometric sorting of TNFR2 B cells revealed that TNFR2 and TNFR2 fractions correspond to IL-10 and IL-10 fractions, respectively. Furthermore, CpG-induced TNFR2 B cells were predominantly found in the IgM CD27 B cell subset and spontaneously released immunoglobulin. Finally, our data corroborate the functional impact of TNFR2 by demonstrating that stimulation with a TNFR2 agonist significantly augments IL-10 and IL-6 production in B cells. Altogether, our data highlight a new role for TNFR2 in IL-10-secreting human B lymphocytes along with the potential to exploit this finding for sorting and isolation of this currently ill-defined B cell subset.

摘要

B细胞衍生的白细胞介素-10(IL-10)的产生已被描述为B淋巴细胞调节功能的一个标志。然而,关于分泌IL-10的B细胞的起源一直存在争议,并且缺乏特异性表面标志物已成为研究人类B调节细胞的一个重要障碍。在本研究中,我们提出肿瘤坏死因子受体2(TNFR2)的表达可用于富集分泌IL-10的B细胞。我们的数据证实,用CpG ODN进行TLR9刺激可诱导IL-10的产生,并且IL-10的分泌伴随着外周血B细胞分化为浆母细胞。我们进一步表明,CpG ODN刺激可诱导TNFR2表达,这与IL-10分泌和终末分化相关。事实上,对TNFR2+B细胞进行流式细胞术分选显示,TNFR2+和TNFR2-组分分别对应于IL-10+和IL-10-组分。此外,CpG诱导的TNFR2+B细胞主要存在于IgM+CD27+B细胞亚群中,并自发释放免疫球蛋白。最后,我们的数据通过证明用TNFR2激动剂刺激可显著增强B细胞中IL-10和IL-6的产生,证实了TNFR2的功能影响。总之,我们的数据突出了TNFR2在分泌IL-10的人类B淋巴细胞中的新作用,以及利用这一发现对目前定义不明确的B细胞亚群进行分选和分离的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/64912118933e/fimmu-08-01951-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/679bf577d4e5/fimmu-08-01951-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/2fba2125e029/fimmu-08-01951-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/65d63a754388/fimmu-08-01951-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/3c5bead692be/fimmu-08-01951-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/18cd3d9266ea/fimmu-08-01951-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/877d000949eb/fimmu-08-01951-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/5c859fef9b44/fimmu-08-01951-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/64912118933e/fimmu-08-01951-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/679bf577d4e5/fimmu-08-01951-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/2fba2125e029/fimmu-08-01951-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/65d63a754388/fimmu-08-01951-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/3c5bead692be/fimmu-08-01951-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/18cd3d9266ea/fimmu-08-01951-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/877d000949eb/fimmu-08-01951-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/5c859fef9b44/fimmu-08-01951-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0407/5780339/64912118933e/fimmu-08-01951-g008.jpg

相似文献

1
Expression of Tumor Necrosis Factor Receptor 2 Characterizes TLR9-Driven Formation of Interleukin-10-Producing B Cells.肿瘤坏死因子受体2的表达表征了Toll样受体9驱动的产生白细胞介素-10的B细胞的形成。
Front Immunol. 2018 Jan 19;8:1951. doi: 10.3389/fimmu.2017.01951. eCollection 2017.
2
TNFR2 expression is a hallmark of human memory B cells with suppressive function.TNFR2 表达是具有抑制功能的人类记忆 B 细胞的标志。
Eur J Immunol. 2021 May;51(5):1195-1205. doi: 10.1002/eji.202048988. Epub 2021 Mar 8.
3
Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.胞苷-磷酸-鸟苷寡核苷酸通过激活牙髓细胞中的 TLR9、MyD88、NF-κB 和 ERK 通路诱导白细胞介素-8 的产生。
J Endod. 2012 Jun;38(6):780-5. doi: 10.1016/j.joen.2012.02.026. Epub 2012 Apr 4.
4
Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.Toll 样受体 9 的激活诱导人 B 细胞表面表达膜结合 B 细胞激活因子 (BAFF),并导致对可溶性和膜结合 BAFF 的反应性增殖增加。
Rheumatology (Oxford). 2013 Jul;52(7):1190-201. doi: 10.1093/rheumatology/ket006. Epub 2013 Feb 21.
5
IL-10 secreting CD21⁺ B cells are present in jejunal Peyer's patches of sheep during fetal development.在胎儿发育期间,分泌白细胞介素-10的CD21⁺ B细胞存在于绵羊空肠派尔集合淋巴结中。
Cell Tissue Res. 2014 May;356(2):417-25. doi: 10.1007/s00441-014-1803-2. Epub 2014 Apr 6.
6
Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro.Toll 样受体 9 的激活增强了体外 B 细胞激活因子和白细胞介素-21 诱导的抗蛋白酶 3 自身抗体的产生。
Rheumatology (Oxford). 2016 Jan;55(1):162-72. doi: 10.1093/rheumatology/kev293. Epub 2015 Aug 28.
7
Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif.含GTCGTT基序的CpG寡脱氧核苷酸(ODN 2059)对牛B淋巴细胞、单核细胞和巨噬细胞中白细胞介素-6和白细胞介素-12的诱导作用。
J Interferon Cytokine Res. 2001 Oct;21(10):871-81. doi: 10.1089/107999001753238123.
8
CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.CpG寡脱氧核苷酸对人扁桃体B细胞的CD40依赖性和非依赖性激活
Eur J Immunol. 2003 Jun;33(6):1576-85. doi: 10.1002/eji.200323444.
9
Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.自身免疫性甲状腺疾病患者和健康对照者的调节性B细胞和T细胞反应。
Dan Med J. 2016 Feb;63(2).
10
Evidence for the existence of regulatory and effector B cell populations in Peyer's patches of sheep.绵羊派伊尔氏结中调节性和效应性B细胞群体存在的证据。
Vet Immunol Immunopathol. 2016 Jun;174:26-34. doi: 10.1016/j.vetimm.2016.04.006. Epub 2016 Apr 8.

引用本文的文献

1
Tumor necrosis factor receptor 2 in allergen tolerance: a perspective view.变应原耐受中的肿瘤坏死因子受体2:前瞻性观点
Front Immunol. 2025 Jun 19;16:1613719. doi: 10.3389/fimmu.2025.1613719. eCollection 2025.
2
Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer.了解 TNFR2 信号在乳腺癌肿瘤微环境中的作用。
J Exp Clin Cancer Res. 2024 Nov 28;43(1):312. doi: 10.1186/s13046-024-03218-1.
3
Therapeutic effect of three-dimensional hanging drop cultured human umbilical cord mesenchymal stem cells on osteoarthritis in rabbits.

本文引用的文献

1
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs.用拮抗抗体靶向肿瘤坏死因子受体2(TNFR2)可抑制卵巢癌细胞和肿瘤相关调节性T细胞(Tregs)的增殖。
Sci Signal. 2017 Jan 17;10(462):eaaf8608. doi: 10.1126/scisignal.aaf8608.
2
Transmembrane tumor necrosis factor-α promotes the recruitment of MDSCs to tumor tissue by upregulating CXCR4 expression via TNFR2.跨膜肿瘤坏死因子-α通过TNFR2上调CXCR4表达,促进骨髓来源的抑制细胞向肿瘤组织募集。
Int Immunopharmacol. 2017 Mar;44:143-152. doi: 10.1016/j.intimp.2016.12.028. Epub 2017 Jan 14.
3
Decreased level of interleukin-10-producing B cells in patients with pemphigus but not in patients with pemphigoid.
三维悬滴培养人脐带间充质干细胞治疗兔骨关节炎的疗效。
Stem Cell Res Ther. 2024 Sep 18;15(1):311. doi: 10.1186/s13287-024-03905-y.
4
Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis.人类调节性记忆 B 细胞通过 TIM-1 和 TIGIT 的表达来定义,在多发性硬化症中功能失调。
Front Immunol. 2024 Apr 30;15:1360219. doi: 10.3389/fimmu.2024.1360219. eCollection 2024.
5
Regulatory B Cells in Solid Organ Transplantation: From Immune Monitoring to Immunotherapy.实体器官移植中的调节性 B 细胞:从免疫监测到免疫治疗。
Transplantation. 2024 May 1;108(5):1080-1089. doi: 10.1097/TP.0000000000004798. Epub 2023 Oct 2.
6
Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS.依那西普联合替奈普酶序贯治疗改善多发性硬化症人源化小鼠模型的转归。
J Neuroinflammation. 2023 May 3;20(1):106. doi: 10.1186/s12974-023-02785-y.
7
TFNR2 in Ischemia-Reperfusion Injury, Rejection, and Tolerance in Transplantation.TFNR2 在移植中的缺血再灌注损伤、排斥和耐受。
Front Immunol. 2022 Jul 7;13:903913. doi: 10.3389/fimmu.2022.903913. eCollection 2022.
8
Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy.肿瘤坏死因子受体2(TNFR2):癌症治疗中一个新兴的靶点。
Cancers (Basel). 2022 May 25;14(11):2603. doi: 10.3390/cancers14112603.
9
Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer.靶向肿瘤坏死因子受体2(TNFR2):癌症治疗中的一项新突破。
Front Oncol. 2022 Apr 14;12:862154. doi: 10.3389/fonc.2022.862154. eCollection 2022.
10
Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity.靶向 TNFR2 的拮抗抗体抑制调节性 T 细胞功能,从而促进抗肿瘤活性。
Front Immunol. 2022 Feb 16;13:835690. doi: 10.3389/fimmu.2022.835690. eCollection 2022.
天疱疮患者体内产生白细胞介素-10 的 B 细胞水平降低,但类天疱疮患者则不然。
Br J Dermatol. 2017 May;176(5):1204-1212. doi: 10.1111/bjd.15113. Epub 2017 Mar 8.
4
TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases.TNFα 在类风湿关节炎和其他自身免疫性炎症性疾病中对 Treg 和 Th17 细胞的调节作用。
Cytokine. 2018 Jan;101:4-13. doi: 10.1016/j.cyto.2016.09.001. Epub 2016 Sep 14.
5
Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy.表型筛选显示TNFR2是癌症免疫治疗的一个有前景的靶点。
Oncotarget. 2016 Oct 18;7(42):68278-68291. doi: 10.18632/oncotarget.11943.
6
Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion.外源性肿瘤坏死因子受体2(TNFR2)激活通过宿主调节性T细胞(T reg)扩增来预防急性移植物抗宿主病(GvHD)。
J Exp Med. 2016 Aug 22;213(9):1881-900. doi: 10.1084/jem.20151563. Epub 2016 Aug 15.
7
Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.调节性 T 细胞通过 T 细胞产生的 TNF 和调节性 T 细胞表达的 TNFR2 来控制移植物抗宿主病。
Blood. 2016 Sep 22;128(12):1651-9. doi: 10.1182/blood-2016-02-700849. Epub 2016 Aug 9.
8
A TNFR2-Agonist Facilitates High Purity Expansion of Human Low Purity Treg Cells.一种肿瘤坏死因子受体2激动剂促进人低纯度调节性T细胞的高纯度扩增。
PLoS One. 2016 May 25;11(5):e0156311. doi: 10.1371/journal.pone.0156311. eCollection 2016.
9
Treg activation defect in type 1 diabetes: correction with TNFR2 agonism.1 型糖尿病中的 Treg 激活缺陷:用 TNFR2 激动剂纠正。
Clin Transl Immunology. 2016 Jan 8;5(1):e56. doi: 10.1038/cti.2015.43. eCollection 2016 Jan.
10
Porphyromonas gingivalis Outer Membrane Vesicles Induce Selective Tumor Necrosis Factor Tolerance in a Toll-Like Receptor 4- and mTOR-Dependent Manner.牙龈卟啉单胞菌外膜囊泡以Toll样受体4和mTOR依赖的方式诱导选择性肿瘤坏死因子耐受性。
Infect Immun. 2016 Mar 24;84(4):1194-1204. doi: 10.1128/IAI.01390-15. Print 2016 Apr.